Stay updated on Nivolumab in Resectable NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Resectable NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Resectable NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and Revision: v3.4.1 along with a government funding status notice were removed. These are housekeeping updates that do not affect the study details or trial information.
    Difference
    0.3%
    Check dated 2026-02-11T11:27:37.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Introduced a government funding lapse notice on the page and updated the revision tag from v3.4.0 to v3.4.1.
    Difference
    0.3%
    Check dated 2026-02-04T06:55:26.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page gains a glossary toggle and updated metadata fields (Last Update Submitted that Met QC Criteria, Last Update Posted) along with a new revision tag (v3.4.0), while related older metadata items are removed. These changes pertain to navigation/maintenance rather than study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T05:33:52.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page. The new revision is now displayed in place of the previous version.
    Difference
    0.0%
    Check dated 2026-01-14T02:40:21.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Locations section added with Maryland, New York, Washington, and Quebec sites; the older location blocks were removed and the page revision updated to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T17:19:37.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Timestamp-related fields such as 'Last Update Posted (Estimated)' and recent dates (e.g., 2025-11-17, 2025-11) were updated. No changes were made to the study content, arms, or eligibility criteria.
    Difference
    0.2%
    Check dated 2025-12-09T02:09:38.000Z thumbnail image

Stay in the know with updates to Nivolumab in Resectable NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resectable NSCLC Clinical Trial page.